Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02055235 · ClinicalTrials.gov registry record
Study of Pain Processing in Experienced Yoga Practitioners
A clinical trial of Pain, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- 47
- Enrollment target
- 1
- Study location
NCT02055235: Completed study of Pain, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT02055235 is a study of Pain that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 47 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02055235, a study of Pain, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Different people perceive the same pain differently. Mood, attention, stress, and personality affect how we feel pain. Researchers want to know whether people who do yoga perceive pain differently than people who do not practice yoga, meditation, or martial arts. They also want to study if cortisol, a stress hormone, relates to pain or brain differences. Objective: \- To study the effects of yoga on the body s stress response, pain perception, and the brain s structure and pain response. Eligibility: * Right-handed adults 30 years and older who practice yoga regularly. * Healthy right-handed volunteers 30 years and older who do at least mild exercise but no yoga or martial arts. Design: * Visit 1: Participants will be screened with medical history and physical exam. They will have blood and urine tests and electrocardiogram to measure heart activity. * At home, participants will wear a heart monitor for 1 day and collect 5 saliva samples daily for seven days. * Visit 2: Participants will undergo tests in a chair or in a mock MRI machine. They will lie on a table that slides into a cylinder. * A heating device will be placed on their leg and heated periodically for few seconds at a time. * They will give saliva samples. * Heart rate, respiration, etc. will be monitored. * They will fill out questionnaires. * Visit 3: Participants will answer questions and repeat Visit 2 tests. Tests will be done in the real MRI machine. The scanner makes loud knocking sounds. Participants will get earplugs. Participants will be in the scanner about 1 hour with a coil over their head.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2014-01-27 |
| Est. Completion | 2016-10-12 |
What the finished NCT02055235 record still lists
NCT02055235 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT02055235 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02055235 about?
NCT02055235 is a clinical study titled "Study of Pain Processing in Experienced Yoga Practitioners". Background: \- Different people perceive the same pain differently. Mood, attention, stress, and personality affect how we feel pain. Researchers want to know whether people who do yoga perceive pain differently than people who do not practice yoga, meditation, or martial arts. They also want to st...
What is the current status of trial NCT02055235?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2014-01-27. Estimated completion is 2016-10-12.
What conditions does trial NCT02055235 study?
This clinical trial studies the following conditions: Pain.
Who is sponsoring clinical trial NCT02055235?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02055235 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02055235's enrollment target sits among peer trials
47 267th of 374 higher than 108 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI